Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael A. Kramarz,
certify that:
| (1) | I have reviewed this Quarterly Report on Form 10-Q of Oncologix Tech, Inc.; |
| (2) | Based on my knowledge, the Report does not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by the Report; |
| (3) | Based on my knowledge, the financial statements, and other financial information included in the
Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods represented in this report; |
| (4) | The registrant’s other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (c) | such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others with these entities, particularly during the period in which this
Report is being prepared; |
| (d) | Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented
in Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and |
| (d) | Disclosed in this Report any change in the registrant’s internal control over financial reporting
that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in case of
an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting. |
| (6) | The registrant’s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit
committee of the Registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: January 2013
By: /s/ Michael A. Kramarz
Michael A. Kramarz
Chief Financial Officer
